Top

Published in:

01-10-2014 | Neurology and Preclinical Neurological Studies - Short communication

Botulinum toxin A in functional popliteal entrapment syndrome: a new approach to a difficult diagnosis

Published in: Journal of Neural Transmission | Issue 10/2014

Abstract

Functional Popliteal Entrapment Syndrome (FPES) is caused by compression of neurovascular structures in the popliteal fossa by hypertrophic muscles, provoking severe leg pain with exercise. Treatment is limited to myotomy of hypertrophic musculature. 8 FPES patients underwent imaging and exercise studies, before receiving botulinum toxin A injections (BTX-A) into the gastrocnemius and plantaris muscles. 81.3 % of patients reported clinical improvement on follow-up, and pathological ankle–brachial indices were normalized. BTX-A injection may present a new, safe, effective and non-invasive approach to FPES.

Available only for authorised users

Bouhoutsos J, Daskalakis E (1981) Muscular abnormalities affecting the popliteal vessels. Br J Surg 68:501–506PubMedCrossRef

Danielson K, Odderson IR (2008) Botulinum toxin type A improves blood flow in vascular thoracic outlet syndrome. Am J Phys Med Rehabil 87:956–959. doi:10.1097/PHM.0b013e31818a51c3 PubMedCrossRef

Erdoes LS, Devine JJ, Bernhard VM, Baker MR, Berman SS, Hunter GC (1994) Popliteal vascular compression in a normal population. J Vasc Surg 20:978–986PubMedCrossRef

Fowkes F, Rudan D, Rudan I, Aboyans V, Denenberg J, McDermott M, Norman P, Sampson U, Williams L, Mensah G, Criqui M (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382:1329–1340PubMedCrossRef

Fowl R, Kempczinski R (2000) Popliteal artery entrapment. In: Rutherford RB (ed) Vascular surgery, 5th edn. Pa Saunders, Philadelphia, pp 1087–1093

Gibson MH, Mills JG, Johnson GE, Downs AR (1977) Popliteal entrapment syndrome. Ann Surg 185:341–348PubMedCrossRefPubMedCentral

Hamming JJ, Vink M (1965) Obstruction of the popliteal artery at an early age. J Cardiovasc Surg (Torino) 6:516–524

Hoffmann U, Vetter J, Rainoni L, Leu AJ, Bollinger A (1997) Popliteal artery compression and force of active plantar flexion in young healthy volunteers. J Vasc Surg 26:281–287PubMedCrossRef

Kirschner JS, Foye PM, Cole JL (2009) Piriformis syndrome, diagnosis and treatment. Muscle Nerve 40:10–18. doi:10.1002/mus.21318 PubMedCrossRef

Love JW, Whelan TJ (1965) Popliteal artery entrapment syndrome. Am J Surg 109:620–624PubMedCrossRef

Reichel G, Hartmann R, Stenner A (2011) Poster: Botulinumtoxin A beim neurogenen Thoracic Outlet Syndrom—ein Erfahrungsbericht über 16 behandelte Patienten. German Botulinumtoxin-Congress

Rignault DP, Pailler JL, Lunel F (1985) The “functional” popliteal entrapment syndrome. Int Angiol 4:341–343PubMed

Schroeder AS, Ertl-Wagner B, Britsch S, Schröder JM, Nikolin S, Weis J, Müller-Felber W, Koerte I, Stehr M, Berweck S, Borggraefe I, Heinen F (2009) Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers. Mov Disord 24:1494–1503. doi:10.1002/mds.22661 PubMedCrossRef

Sinha S, Houghton J, Holt PJ, Thompson MM, Loftus IM, Hinchliffe RJ (2012) Popliteal entrapment syndrome. J Vasc Surg 55(252–262):e30. doi:10.1016/j.jvs.2011.08.050 PubMed

Stuart TP (1879) Note on a variation in the course of the popliteal artery. J Anat Physiol 13:162PubMedPubMedCentral

Turnipseed WD (2004) Clinical review of patients treated for atypical claudication: a 28-year experience. J Vasc Surg 40:79–85. doi:10.1016/j.jvs.2004.02.034 PubMedCrossRef

Turnipseed WD (2009) Functional popliteal artery entrapment syndrome: a poorly understood and often missed diagnosis that is frequently mistreated. J Vasc Surg 49:1189–1195. doi:10.1016/j.jvs.2008.12.005 PubMedCrossRef

Turnipseed WD, Pozniak M (1992) Popliteal entrapment as a result of neurovascular compression by the soleus and plantaris muscles. J Vasc Surg 15:285–293 (discussion 293–4)PubMedCrossRef

WeMove (2005) Management of spasticity with Botulinum toxin type A (Botox)—suggested adult Botox dosing, 3rd edn. WeMove; 2005. Available at http://www.mdvu.org

Title: Botulinum toxin A in functional popliteal entrapment syndrome: a new approach to a difficult diagnosis
Publication date: 01-10-2014
Published in: Journal of Neural Transmission / Issue 10/2014
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-014-1197-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Botulinum toxin A in functional popliteal entrapment syndrome: a new approach to a difficult diagnosis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2014

Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson’s disease and in hepatic encephalopathy

6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson’s disease: respirometric, histological, and behavioral analyses

Carotid artery thickening and neurocirculatory abnormalities in de novo Parkinson disease

Subacute peripheral neuropathy under duodopa therapy without cobalamin deficiency and despite supplementation

Stem cell therapy: a new approach to the treatment of refractory depression

Lenticular nucleus hyperechogenicity in Wilson’s disease reflects local copper, but not iron accumulation